TETRAPHASE PHARMACEUTICALS I - COM (TTPH)

CUSIP: 88165N105

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM
Total 13F shares
23,467,200
Share change
-2,820,006
Total reported value
$108,664,000
Put/Call ratio
28%
Price per share
$4.63
Number of holders
98
Value change
-$21,707,431
Number of buys
51
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 88165N105?
CUSIP 88165N105 identifies TTPH - TETRAPHASE PHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TETRAPHASE PHARMACEUTICALS I - COM (TTPH) as of Q1 2016

As of 31 Mar 2016, TETRAPHASE PHARMACEUTICALS I - COM (TTPH) was held by 98 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,467,200 shares. The largest 10 holders included GREAT POINT PARTNERS LLC, CANADA PENSION PLAN INVESTMENT BOARD, FMR LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, WELLINGTON MANAGEMENT GROUP LLP, RENAISSANCE TECHNOLOGIES LLC, BlackRock Institutional Trust Company, N.A., NUMERIC INVESTORS LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 98 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.